New diabetes clinical trial: Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients with Hematological Malignancies and Subjected to Treatment with Immune-checkpoint Inhibitors

Published on: February 27, 2025 at 11:00PM
Conditions: Hematological Malignancies
Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
https://ift.tt/d85DAxJ